Figure 2.

Cumulative incidence curves of time to breakthrough-invasive fungal disease (n = 26) stratified by acute leukemia and allogeneic hematopoietic stem cell transplant (Allo-HSCT ) status. This was taken from date of leukemia diagnosis and date of HSCT to 3-year interval. Cumulative incidence in percentages are as follows: overall, 13.8% (95% confidence interval [CI], 9.53 to 19.9); acute myeloid leukemia (AML), 6.75% (95% CI, 3.85 to 11.7); acute lymphoblastic leukemia (ALL), 2.69% (95% CI, 1.13 to 6.34); and Allo-HSCT, 2.48% (95% CI, 0.93 to 6.51).